UNB, Dhaka :
ICDDR,B scientist Dr Md Jobayer Chisti has been honoured with People’s Choice Award for the most promising childhood pneumonia innovation, receiving over 1000 votes in an online global voting competition on the Facebook.
He received the award at the Pneumonia
Innovations Summit in New York recently where he also presented his low-cost technology for providing oxygen to infants suffering from severe pneumonia and hypoxemia, called bubble-CPAP, said an ICDDR-B media note on Monday.
Speaking on the occasion, Dr Chisti said he is delighted to receive the People’s Choice Award. “I’ll be even happier if the World Health Organization recommends this low-cost bubble-CPAP treatment as the standard therapy for children with severe pneumonia and hypoxemia in developing countries,” he said.
Dr Chisti’s affordable bubble-CPAP unit uses cheap equipment like a shampoo bottle and plastic tubing, so it is easy to access and simple to put together.
A recent clinical trial published in The Lancet has shown that Dr Chisti’s low-cost bubble-CPAP was associated with fewer deaths and treatment failures in under-five children with severe pneumonia compared to the World Health Organization’s recommended standard low-flow oxygen treatment.
More than 50 innovators and 150 global health leaders assembled at the inaugural Pneumonia Innovations Summit in New York to coincide with World Pneumonia Day.
The next generation of pneumonia prevention, diagnostic and treatment innovations were unveiled at the event.
ICDDR,B scientist Dr Md Jobayer Chisti has been honoured with People’s Choice Award for the most promising childhood pneumonia innovation, receiving over 1000 votes in an online global voting competition on the Facebook.
He received the award at the Pneumonia
Innovations Summit in New York recently where he also presented his low-cost technology for providing oxygen to infants suffering from severe pneumonia and hypoxemia, called bubble-CPAP, said an ICDDR-B media note on Monday.
Speaking on the occasion, Dr Chisti said he is delighted to receive the People’s Choice Award. “I’ll be even happier if the World Health Organization recommends this low-cost bubble-CPAP treatment as the standard therapy for children with severe pneumonia and hypoxemia in developing countries,” he said.
Dr Chisti’s affordable bubble-CPAP unit uses cheap equipment like a shampoo bottle and plastic tubing, so it is easy to access and simple to put together.
A recent clinical trial published in The Lancet has shown that Dr Chisti’s low-cost bubble-CPAP was associated with fewer deaths and treatment failures in under-five children with severe pneumonia compared to the World Health Organization’s recommended standard low-flow oxygen treatment.
More than 50 innovators and 150 global health leaders assembled at the inaugural Pneumonia Innovations Summit in New York to coincide with World Pneumonia Day.
The next generation of pneumonia prevention, diagnostic and treatment innovations were unveiled at the event.
